This is a very exciting time for multiple myeloma (MM) research, with advances in a range of areas from new...

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review!  For more news visit www.vjhemonc.com

Medicine

Health & Fitness

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Share Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances

Sign up to save your podcasts

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances

Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances